Advanced analytics and AI applied to Australian healthcare — transforming complex operational, clinical, and market data into decisions that move the needle.
Across retail pharmacy, hospital networks, pharmaceutical companies, and health insurers — these are the decisions where better data changes outcomes.
Modelling the commercial impact of PBS listings, PBAC decisions, and government subsidy changes on patient access, brand performance, and therapeutic category dynamics.
Architecting scalable data pipelines and resilient analytics infrastructure — from source ingestion and transformation to curated data products, quality assurance, and operational monitoring.
Anticipating product demand across pharmacy networks and hospital supply chains — accounting for seasonality, PBS policy changes, shortage signals, and demographic shifts.
Identifying high-value patient segments, prescriber territories, and market penetration opportunities — informing sales force deployment, pricing strategy, and portfolio decisions.
Using AI and longitudinal analytics to understand treatment adherence, therapy persistence, and dropout patterns — helping identify intervention opportunities, improve patient support, and strengthen brand performance.
Applying AI and advanced analytics to uncover treatment patterns, patient outcomes, and real-world utilisation trends — supporting evidence generation, strategy development, and more informed healthcare decisions.
Great analytics doesn't start with algorithms — it starts with understanding the question. Our process is built for healthcare's complexity.
Australia's healthcare AI adoption is accelerating — but success depends on fit for purpose, regulatory alignment, and genuine integration with clinical and operational workflows. We evaluate AI through that lens.
Whether you need to build an analytics capability, evaluate an AI tool, or understand what your data is actually telling you — the conversation starts here.